The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSeed Innov Regulatory News (SEED)

Share Price Information for Seed Innov (SEED)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.05
Bid: 2.00
Ask: 2.10
Change: 0.00 (0.00%)
Spread: 0.10 (5.00%)
Open: 2.05
High: 2.05
Low: 2.05
Prev. Close: 2.05
SEED Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan to Portfolio Company, Leap Gaming

8 Jun 2022 15:05

RNS Number : 1993O
Seed Innovations Limited
08 June 2022
 

Seed Innovations Ltd / AIM: SEED / Sector: Closed End Investments

8 June 2022

SEED Innovations Limited ("SEED" or the "Company")

 

Loan to Portfolio Company, Leap Gaming

 

SEED Innovations Limited, the AIM quoted company investing in fast growing and industry leading businesses with a focus on the medical cannabis, health and wellness space  announces that it has provided a Term Loan of up to €250,000 to portfolio company Fralis LLC, trading as Leap Gaming ('Leap'), an Israel based B2B developer of high-end 3D gaming applications whose games are offered by leading online and retail gaming operators worldwide (the 'Term Loan').

 

The Company and Leap have agreed that the Term Loan will be drawn down in tranches, with the first tranche of €100,000 drawn down initially. Further drawdowns of the Term Loan may be drawn in one or more tranches with the agreement of SEED.

 

The Term Loan will be used for working capital purposes as Leap advances towards a liquidity event by way of either an initial public offer of its shares or reverse takeover transaction, anticipated in late 2022.

 

The Term Loan will be payable on completion of certain conditions precedent, including the payment of a €10,000 arrangement fee by Leap to SEED, which are expected to be satisfied imminently.

 

Ed McDermott, CEO of SEED, commented: "We are pleased to be able to further support Leap, one of our long term and largest investments, at a time in which we believe there is significant progress being made operationally. Following the milestone award of the content supply license by the UKGC to Leap, and most recently a license to enter into the Lithuanian market, we anticipate support for Leap's growth and we will work with the board of Leap towards a liquidity event over the coming months."

 

Principal Terms of the Term Loan

· The Term Loan attracts interest of 10% per annum, payable on the 6 April 2023, being the repayment date

· The Term Loan is repayable as follows:

o on the earlier of 6 April 2023; or

o immediately on the Leap completing any Qualifying Financing (including (i) in one or more transactions (aggregated over a period of 12 months), raising equity capital of greater than €1,000,000 from existing or new investors; or (ii) completing an initial public offer of its shares (including by way of reverse takeover transaction or similar); or (iii) a sale of any assets of Leap realising proceeds greater than € 250,000

· €10,000 arrangement fee payable by Leap to SEED

 

 

 

 

Schedule 4 Disclosure

SEED has a total amount of approximately £4.7 million invested in Leap as at the last balance sheet date (comprised of circa £633,000 (€733,000) by way of convertible loan notes and £4.07 million in equity), representing approximately 43.75% of Leap (on a fully diluted basis).

 

SEED expects to carry its investment in Leap at a value of c.£8.27 million as at 31 March 2022.

 

About Leap Gaming

 

Leap is a developer of high-end virtual-sports, slots, and casino applications serving hundreds of gaming brands and generating tens of thousands of engagement points with end-users. Leap's attention to detail in its solutions and services is manifested in the modular engagement terms it offers to its operating partners and its ability to provide seamless experiences across mobile, desktop and retail environments. Leap is licensed by the MGA and certified for other jurisdictions worldwide. Unaudited turnover for the year to 31 December 2021 was €3.1 million, with operating profit of €615,000.The recent licensing news such as the granting of a content supply license by the United Kingdom Gaming Commission ("UKGC")] is a significant milestone for Leap, allowing it to access the lucrative UK gaming market, which, according to the UKGC, the regulated gambling industry in Great Britain generated a gross gambling yield ("GGY") of £14.1bn during the period April 2019 to Mar 2021. The UKGC license is added to the other recent licenses obtained by Leap in Sweden, the Netherlands, Romania, South Africa and Greece.

 

 

 

***ENDS***

 

For further information on the Company please visit  www.seedinnovations.co or contact:

 

 

Ed McDermott

Lance de Jersey

SEED Innovations Ltd

E: info@seedinnovations.co

 

James Biddle

Roland Cornish

Beaumont Cornish Limited,

Nomad

T: (0)20 7628 3396

 

Isabella Pierre

Damon Heath

Shard Capital Partners LLP

Broker

T: (0)20 7186 9927

Catherine Leftley

Isabelle Morris

St Brides Partners Ltd,

Financial PR

E: info@stbridespartners.co.uk

 

 

Notes

SEED Innovations is an AIM quoted investment company focused primarily on disruptive high growth life sciences and technology businesses particularly within the medical cannabis arena. The Company's strategy is to identify early-stage opportunities that have an upcoming investment catalyst and grow its portfolio in terms of value whilst limiting the number of investee companies to a level where relevant time can be devoted to each.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCUPUGUQUPPGCR
Date   Source Headline
26th Apr 20244:46 pmRNSTransaction in Own Shares
25th Apr 202411:03 amRNSTransaction in Own Shares
24th Apr 20243:14 pmRNSTransaction in Own Shares & TVR
23rd Apr 202411:11 amRNSTransaction in Own Shares
22nd Apr 202411:33 amRNSTransaction in Own Shares
19th Apr 202410:55 amRNSTransaction in Own Shares & TVR
18th Apr 20241:20 pmRNSTransaction in Own Shares
17th Apr 20242:57 pmRNSInvestee Company Update: Little Green Pharma Ltd
17th Apr 202411:55 amRNSTransaction in Own Shares & TVR
16th Apr 20247:00 amRNSSpecial Dividend Declaration
15th Apr 20243:20 pmRNSTransaction in Own Shares
15th Apr 20247:00 amRNSReceipt of remaining £2.4m from sale of Leap
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares & TVR
9th Apr 20241:00 pmRNSInvestee Company Update: Northern Leaf plc
8th Apr 202412:20 pmRNSTransaction in Own Shares & TVR
5th Apr 20248:25 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20243:34 pmRNSTransaction in Own Shares & TVR
26th Mar 20241:03 pmRNSTransaction in Own Shares
26th Mar 20247:48 amRNSInvestee Company Update: Clean Food Group
25th Mar 20243:40 pmRNSTransaction in Own Shares & TVR
25th Mar 20247:00 amRNSTransaction in Own Shares & TVR
21st Mar 202410:25 amRNSTransaction in Own Shares & TVR
21st Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20242:30 pmRNSInvestee Company Update: Northern Leaf
13th Mar 202412:23 pmRNSTransaction in Own Shares & TVR
12th Mar 202412:19 pmRNSTransaction in Own Shares & TVR
11th Mar 202411:27 amRNSTransaction in Own Shares & TVR
7th Mar 20241:09 pmRNSTransaction in Own Shares
7th Mar 20249:08 amRNSTransaction in Own Shares & TVR
29th Feb 20249:00 amRNSContinuation of Existing Share Buy-Back Programme
20th Feb 20244:00 pmRNSInvestee Company Update: Little Green Pharma Ltd
19th Feb 20247:00 amRNSTransaction in Own Shares & TVR
13th Feb 20247:00 amRNSTransaction in Own Shares
9th Feb 20247:00 amRNSTransaction in Own Shares & TVR
8th Feb 20247:00 amRNSTransaction in Own Shares & TVR
7th Feb 20247:00 amRNSTransaction in Own Shares & TVR
5th Feb 20242:00 pmRNSTransaction in Own Shares & TVR
1st Feb 20243:22 pmRNSTransaction in Own Shares & TVR
1st Feb 202410:06 amRNSInvestee Company Update: Little Green Pharma Ltd
26th Jan 20247:00 amRNSTransaction in Own Shares & TVR
25th Jan 20243:03 pmRNSInvestee Company Update: Avextra AG Raises €3.3m
25th Jan 20247:00 amRNSTransaction in Own Shares & TVR
24th Jan 20247:00 amRNSInvestee Company Update: Avextra AG
23rd Jan 20247:00 amRNSInvestee Company Update: Avextra AG
23rd Jan 20247:00 amRNSTransaction in Own Shares & TVR
22nd Jan 20247:00 amRNSCEO Presenting at Proactive One2One Investor Forum
19th Jan 20246:23 pmRNSDirector/PDMR Shareholding
4th Jan 20247:00 amRNSTransaction in Own Shares & TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.